How the pandemic affected Stryker’s Q1 earnings & more: 6 device company notes

Here are six key notes on spine and orthopedic device companies:

Advertisement

Stryker reported the COVID-19 pandemic has had a significant negative effect on its operations and financials this year, which started out strong. Read more.

Precision Spine commercially launched its ShurFit ACIF 2C Anterior Cervical, TLIF 2C Interbody Fusion and TPLIF 2C Posterior Interbody systems in the U.S.  

Zimmer Biomet recently donated personal protective equipment to the rehabilitation unit at St. Joseph’s Hospital in Ennis, Ireland. 

NuVasive on May 5 expanded its advanced materials science implant portfolio with two FDA 510(k) clearances and one device launch.

Safe Orthopaedics eased some of the partial activity measures for its German commercial team.

The FDA on April 30 provided 510(k) clearance for Astura Medical’s El Capitan anterior lumbar interbody fusion system.

More articles on healthcare:
Life after ramp-up: How COVID-19 will change ASCs forever
3 ASC nurses join COVID-19 front lines in New York
4 hospitals, health systems opening ASCs

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.